CDRH National Evaluation System, Mobile Health Apps Interactive Tool
WHAT: To generate evidence across total product lifecycle by leveraging real-world evidence for medical device evaluation and regulatory decision-making
WHY: Quality real-world evidence for health care providers and patients to make informed treatment decisions and balance safety vs device innovation and patient access
WHEN: Initial report in 2012. Included in CDRH 2016-2017 priorities
WHAT: Web-based tool for developers of health-related mobile apps
WHO: Federal Trade Commission (FTC), Dept of Health and Human Services, FDA
WHY: Help developers understand what federal laws and regulations might apply to their apps – FTC Act, HIPAA, FD&C Act